These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1008344)

  • 1. Five- to seven-year course of pulmonary function in cystic fibrosis.
    Corey M; Levison H; Crozier D
    Am Rev Respir Dis; 1976 Dec; 114(6):1085-92. PubMed ID: 1008344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transit time analysis of the forced expiratory vital capacity in cystic fibrosis.
    Neuburger N; Levison H; Kruger K
    Am Rev Respir Dis; 1976 Oct; 114(4):753-9. PubMed ID: 970749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximal expiratory flows after postural drainage.
    Feldman J; Traver GA; Taussig LM
    Am Rev Respir Dis; 1979 Feb; 119(2):239-45. PubMed ID: 434596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the forced expiratory spirogram in young male smokers.
    Walter S; Nancy NR; Collier CR
    Am Rev Respir Dis; 1979 May; 119(5):717-24. PubMed ID: 453697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa.
    Kerem E; Corey M; Gold R; Levison H
    J Pediatr; 1990 May; 116(5):714-9. PubMed ID: 2109790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.
    Wang EE; Prober CG; Manson B; Corey M; Levison H
    N Engl J Med; 1984 Dec; 311(26):1653-8. PubMed ID: 6504106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung function changes in smokers with normal conventional spirometry.
    Marco M; Minette A
    Am Rev Respir Dis; 1976 Oct; 114(4):723-38. PubMed ID: 970748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function, and genotype in children with cystic fibrosis.
    Zemel BS; Kawchak DA; Cnaan A; Zhao H; Scanlin TF; Stallings VA
    Pediatr Res; 1996 Oct; 40(4):578-86. PubMed ID: 8888286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with living-donor lobar transplantation for indications other than cystic fibrosis.
    Starnes VA; Barr ML; Schenkel FA; Horn MV; Cohen RG; Hagen JA; Wells WJ
    J Thorac Cardiovasc Surg; 1997 Dec; 114(6):917-21; discussion 921-2. PubMed ID: 9434686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstruction of the respiratory pathways, its evaluation by methods of functional examination of the lungs and development in patients with cystic fibrosis.
    Houstĕk J; Zapletal A; Samánek M; Vávrová V
    Czech Med; 1979; 2(1-2):1-10. PubMed ID: 527420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung function from infancy to preschool in a cohort of children with cystic fibrosis.
    Brumback LC; Davis SD; Kerby GS; Kloster M; Johnson R; Castile R; Hiatt PW; Hart M; Rosenfeld M
    Eur Respir J; 2013 Jan; 41(1):60-6. PubMed ID: 22653767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving rate of decline of FEV1 in young adults with cystic fibrosis.
    Que C; Cullinan P; Geddes D
    Thorax; 2006 Feb; 61(2):155-7. PubMed ID: 16384880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional growth retardation is associated with defective lung growth in cystic fibrosis: a preventable determinant of progressive pulmonary dysfunction.
    Thomson MA; Quirk P; Swanson CE; Thomas BJ; Holt TL; Francis PJ; Shepherd RW
    Nutrition; 1995; 11(4):350-4. PubMed ID: 8580575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cystic fibrosis mutation associated with mild lung disease.
    Gan KH; Veeze HJ; van den Ouweland AM; Halley DJ; Scheffer H; van der Hout A; Overbeek SE; de Jongste JC; Bakker W; Heijerman HG
    N Engl J Med; 1995 Jul; 333(2):95-9. PubMed ID: 7539891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
    Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
    Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial changes in pulmonary functions in children hospitalized with cystic fibrosis.
    Redding GJ; Restuccia R; Cotton EK; Brooks JG
    Am Rev Respir Dis; 1982 Jul; 126(1):31-6. PubMed ID: 7091906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of high-dose ibuprofen in patients with cystic fibrosis.
    Konstan MW; Byard PJ; Hoppel CL; Davis PB
    N Engl J Med; 1995 Mar; 332(13):848-54. PubMed ID: 7503838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Within-subject variability and per cent change for significance of spirometry in normal subjects and in patients with cystic fibrosis.
    Nickerson BG; Lemen RJ; Gerdes CB; Wegmann MJ; Robertson G
    Am Rev Respir Dis; 1980 Dec; 122(6):859-66. PubMed ID: 7458059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of inhomogeneity of lung units to the maximal expiratory flow-volume curve in children with asthma and cystic fibrosis.
    Landau LI; Taussig LM; Macklem PT; Beaudry PH
    Am Rev Respir Dis; 1975 Jun; 111(6):725-31. PubMed ID: 1137240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.